BLASTOID VARIANT MANTLE CELL LYMPHOMA
Clinical trials for BLASTOID VARIANT MANTLE CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new BLASTOID VARIANT MANTLE CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for BLASTOID VARIANT MANTLE CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for aggressive lymphoma in young patients
Disease control OngoingThis study tests whether giving a targeted drug (ibrutinib) and an immunotherapy (rituximab) before standard chemotherapy can improve outcomes for young patients with newly diagnosed mantle cell lymphoma, an aggressive blood cancer. About 131 participants will receive the combina…
Matched conditions: BLASTOID VARIANT MANTLE CELL LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 11:23 UTC
-
New drug combo shows promise for Tough-to-Treat lymphoma
Disease control OngoingThis study tests a combination of two targeted drugs, venetoclax and acalabrutinib, in 32 patients with mantle cell lymphoma that either returned after treatment or never fully responded. The goal is to see how many patients achieve a complete response, meaning no signs of cancer…
Matched conditions: BLASTOID VARIANT MANTLE CELL LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 19, 2026 11:59 UTC